FDA calendar · November 2020 · built from SEC filings

PDUFA dates November 2020: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in November 2020. The FDA calendar also recorded 14 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in November 2020

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

November 2020: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
November 5, 2020Brilinta (ticagrelor)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
November 6, 2020Cyclophosphamide (cyclophosphamide)RDYComplete Response Letter—CRL issuedFDA Complete Response Letters
November 6, 2020Qelbree (viloxazine hydrochloride)SUPNComplete Response Letter—CRL issuedFDA Complete Response Letters
November 12, 2020Fexinidazole (fexinidazole)SNYComplete Response Letter—CRL issuedFDA Complete Response Letters
November 13, 2020Lybalvi (olanzapine; samidorphan l-malate)ALKSComplete Response Letter—CRL issuedFDA Complete Response Letters
November 13, 2020KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
November 13, 2020Trintellix (vortioxetine hydrobromide)TAKLabel expansion—ApprovedopenFDA Drugs@FDA
November 16, 2020Forteo® (teriparatide)LLYLabel expansion—ApprovedopenFDA Drugs@FDA
November 18, 2020Imfinzi® (durvalumab)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
November 20, 2020Pomalyst (pomalidomide)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
November 20, 2020Erleada (apalutamide)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
November 24, 2020Idhifa (enasidenib mesylate)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
November 24, 2020Rydapt (midostaurin)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
November 25, 2020IMCIVREE® (setmelanotide)RYTMFDA approval—ApprovedopenFDA Drugs@FDA

November 2020: dated readouts

No events in this view.

Questions

What PDUFA dates are in November 2020?

0 PDUFA dates fell in November 2020. The FDA calendar also recorded 14 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.